Regencell Bioscience Holdings Ltd (RGC)
$19.99
As on 09-Jun-2026 13:36EDT
Market cap
$9,885 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
8982.4
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-44.6
-
Debt to Equity
0.1
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
494,488,908
10 Years Aggregate
CFO
$1,938.69 Mln
EBITDA
$2,296.43 Mln
Net Profit
$683.56 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Regencell Bioscience Holdings (RGC)
| -4.8 | -31.7 | -14.4 | 10.8 | 214.2 | -- | -- |
|
BSE Sensex
| -12.7 | -4.4 | -6.3 | -10.1 | 5.6 | 7.2 | 10.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
|---|---|---|---|
|
Regencell Bioscience Holdings (RGC)
| 16,053.8 | -62.4 | -12.4 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Regencell Bioscience Holdings (RGC)
|
20.0 | 9,884.8 | 0.0 | -3.6 | -- | -54.8 | -- | 8,982.4 |
| 1.7 | 70.3 | 0.0 | -7.6 | -- | -- | -- | 5.4 | |
| 9.0 | 833.5 | 79.8 | -120.5 | -132.8 | -- | -- | 228.3 |
Shareholding Pattern
View DetailsAbout Regencell Bioscience Holdings (RGC)
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and... degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. Read more
-
Founder, Chairman & CEO
Mr. Yat-Gai Au
-
Founder, Chairman & CEO
Mr. Yat-Gai Au
-
Headquarters
Causeway Bay
-
Website
FAQs for Regencell Bioscience Holdings (RGC)
What is the current share price of Regencell Bioscience Holdings Ltd (RGC) Today?
The share price of Regencell Bioscience Holdings Ltd (RGC) is $19.99 (NASDAQ) as of 09-Jun-2026 13:36 EDT. Regencell Bioscience Holdings Ltd (RGC) has given a return of 214.21% in the last 3 years.
What is the current PB & PE ratio of Regencell Bioscience Holdings Ltd (RGC)?
Since, TTM earnings of Regencell Bioscience Holdings Ltd (RGC) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
What is the 52 Week High and Low of Regencell Bioscience Holdings Ltd (RGC)?
The 52-week high and low of Regencell Bioscience Holdings Ltd (RGC) are Rs 83.60 and Rs 9.39 as of 10-Jun-2026.
What is the market cap of Regencell Bioscience Holdings Ltd (RGC)?
Regencell Bioscience Holdings Ltd (RGC) has a market capitalisation of $ 9,885 Mln as on 05-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Regencell Bioscience Holdings Ltd (RGC)?
Before investing in Regencell Bioscience Holdings Ltd (RGC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.